Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives

Código QR

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives

Karen Ly,1 Kristen M Beck,1 Mary P Smith,1 Ana-Maria Orbai,2 Wilson Liao11Department of Dermatology, University of California San Francisco, San Francisco, CA, USA; 2Division of Rheumatology, Johns Hopkins University, Baltimore, MD, USACorrespondence: Kristen M BeckDepartment of Dermatology, Univers...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ly K, Beck KM, Smith MP, Orbai AM, Liao W
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Tofacitinib psoriatic arthritis janus kinase kinase inhibitors Dermatology RL1-803
Acceso en línea:	https://doaj.org/article/2be9896c311441df89358ff87576a385
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis
por: Chimenti MS, et al.
Publicado: (2020)

Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib
por: Miguel Nogueira, et al.
Publicado: (2021)

Quality of life in patients with psoriatic arthritis
por: Kseniya Mikhailovna Koreshkova, et al.
Publicado: (2021)

The role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis
por: Zarema R. Khismatullina, et al.
Publicado: (2021)

Baricitinib for the treatment of rheumatoid arthritis
por: Ivan Urits, et al.
Publicado: (2020)

Association of HLA Alleles and HLA Haplotypes with Psoriasis, Psoriatic Arthritis and Disease Severity in a Miscegenated Population
por: Cassia FF, et al.
Publicado: (2021)

The metabolomics of psoriatic disease
por: Yan D, et al.
Publicado: (2017)

Frequency of Health Care Resource Utilization and Direct Medical Costs Associated with Psoriatic Arthritis in a Rheumatic Care Center in Colombia
por: Santos-Moreno P, et al.
Publicado: (2021)

A Successful Treatment of Ostraceous Psoriasis Associated with Psoriatic Arthritis in Children: A Case Report
por: Rowawi R, et al.
Publicado: (2020)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential
por: Chiricozzi A, et al.
Publicado: (2019)

Local effects of adipose tissue in psoriasis and psoriatic arthritis
por: Kruglikov IL, et al.
Publicado: (2017)

Tofacitinib en el tratamiento de la colitis ulcerosa: casos clínicos
por: Quera,Rodrigo, et al.
Publicado: (2020)

The Skin May Clear But the Arthritis Won’t Disappear: Focusing on Concomitant and New-Onset Psoriatic Arthritis in a Daily Practice Cohort of Psoriasis Patients on Biologic Therapy
por: van Muijen ME, et al.
Publicado: (2020)

Genetic markers for psoriatic arthritis in patients with psoriasis. Part I: non-HLA genes
por: Alexey A. Kubanov, et al.
Publicado: (2021)

Low starting dosage of infliximab with possible escalating dosage in psoriatic arthritis gives the same treatment results as standard dosage of adalimumab or etanercept: results from the nationwide Icelandic ICEBIO registry
por: Gudbjornsson B, et al.
Publicado: (2018)

Psoriasis: Targets and Therapy
Publicado: (2012)

Dermoscopic findings of perifollicular pigmentation associated with vandetanib
por: Jade Cury-Martins, et al.
Publicado: (2018)

Management of Rheumatoid Arthritis: An Overview
por: Andrei-Flavius Radu, et al.
Publicado: (2021)

Diffuse scaly erythematous plaques in patient taking poziotinib
por: Reid Oldenburg, MD, PhD, et al.
Publicado: (2022)

Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patients
por: Song Zhang, et al.
Publicado: (2021)

Psoriasis to Psoriatic Arthritis: The Application of Proteomics Technologies
por: Fei Qi, et al.
Publicado: (2021)

AGE-DEPENDENT INDEXES OF IMMUNITY IN THE PATIENTS WITH PSORIATIC ARTHRITIS
por: A. A. Barilo, et al.
Publicado: (2019)

Impact of Etanercept on Vitamin D Status and Vitamin D-binding Protein in Bio-naïve Patients with Psoriasis
por: Maria Siekkeri Vandikas, et al.
Publicado: (2021)

Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast
por: Forchhammer S, et al.
Publicado: (2015)

The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis—Real-World Data from Dermatology Practice
por: Georgios Kokolakis, et al.
Publicado: (2021)

Metastatic papillary thyroid carcinoma to the nose: report and review of cutaneous metastases of papillary thyroid cancer
por: Philip R. Cohen
Publicado: (2015)

Prevalence of Psoriatic Arthritis among Psoriatic Patients in Damietta Governorate
por: Aisha Mohamed, et al.
Publicado: (2019)

Ustekinumab-induced chronic lymphocytic leukemia in a patient with psoriatic arthritis
por: Fusun Gediz, et al.
Publicado: (2021)

IMMUNE PATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
por: S. V. Smirnova, et al.
Publicado: (2014)

Assessing the effectiveness of synthetic and biologic disease-modifying antirheumatic drugs in psoriatic arthritis – a systematic review
por: Kingsley GH, et al.
Publicado: (2015)

Review of the treatment of psoriatic arthritis with biological agents: choice of drug for initial therapy and switch therapy for non-responders
por: D'Angelo S, et al.
Publicado: (2017)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum]
por: Chiricozzi A, et al.
Publicado: (2019)

Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma
por: Andrea Pontara, et al.
Publicado: (2020)

An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy
por: Acosta-Felquer ML, et al.
Publicado: (2016)

Epidemiology, genetics and management of psoriatic arthritis 2013: focus on developments of who develops the disease, its clinical features, and emerging treatment options
por: Haroon M, et al.
Publicado: (2013)

GENETIC FACTORS IN IMMUNOPATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
por: M. V. Smolnikova, et al.
Publicado: (2014)

Editorial: Early Origins of Psoriatic Arthritis
por: David Simon, et al.
Publicado: (2021)

ASSOCIATION BETWEEN POLYMORPHIC MARKERS OF THE IL4 (с-590Т) AND IL10 (с-597А) GENES AND PSORIATIC ARTHRITIS
por: M. V. Smolnikova, et al.
Publicado: (2012)

Abatacept for the treatment of adults with psoriatic arthritis: patient selection and perspectives
por: Noisette A, et al.
Publicado: (2018)

Secukinumab in the treatment of psoriasis: patient selection and perspectives
por: Yang EJ, et al.
Publicado: (2018)